Showing 1 - 6 results of 6 for search 'Alexander G. Allen', query time: 0.03s Refine Results
  1. 1
    Gene Editing of HIV-1 Co-receptors to Prevent and/or Cure Virus Infection

    Gene Editing of HIV-1 Co-receptors to Prevent and/or Cure Virus Infection by Alexander G. Allen, Alexander G. Allen, Cheng-Han Chung, Cheng-Han Chung, Andrew Atkins, Andrew Atkins, Will Dampier, Will Dampier, Will Dampier, Kamel Khalili, Kamel Khalili, Michael R. Nonnemacher, Michael R. Nonnemacher, Michael R. Nonnemacher, Brian Wigdahl, Brian Wigdahl, Brian Wigdahl

    Published 2018-12-01
    Get full text
    Article
  2. 2
    Off-Target Analysis in Gene Editing and Applications for Clinical Translation of CRISPR/Cas9 in HIV-1 Therapy

    Off-Target Analysis in Gene Editing and Applications for Clinical Translation of CRISPR/Cas9 in HIV-1 Therapy by Andrew Atkins, Andrew Atkins, Cheng-Han Chung, Cheng-Han Chung, Alexander G. Allen, Alexander G. Allen, Will Dampier, Will Dampier, Theodore E. Gurrola, Theodore E. Gurrola, Ilker K. Sariyer, Michael R. Nonnemacher, Michael R. Nonnemacher, Brian Wigdahl, Brian Wigdahl, Brian Wigdahl

    Published 2021-08-01
    Get full text
    Article
  3. 3
    Computational Design of gRNAs Targeting Genetic Variants Across HIV-1 Subtypes for CRISPR-Mediated Antiviral Therapy

    Computational Design of gRNAs Targeting Genetic Variants Across HIV-1 Subtypes for CRISPR-Mediated Antiviral Therapy by Cheng-Han Chung, Cheng-Han Chung, Alexander G. Allen, Alexander G. Allen, Andrew Atkins, Andrew Atkins, Robert W. Link, Robert W. Link, Michael R. Nonnemacher, Michael R. Nonnemacher, Michael R. Nonnemacher, Will Dampier, Will Dampier, Brian Wigdahl, Brian Wigdahl, Brian Wigdahl

    Published 2021-03-01
    Get full text
    Article
  4. 4
    Designing Safer CRISPR/Cas9 Therapeutics for HIV: Defining Factors That Regulate and Technologies Used to Detect Off-Target Editing

    Designing Safer CRISPR/Cas9 Therapeutics for HIV: Defining Factors That Regulate and Technologies Used to Detect Off-Target Editing by Neil T. Sullivan, Neil T. Sullivan, Alexander G. Allen, Alexander G. Allen, Andrew J. Atkins, Andrew J. Atkins, Cheng-Han Chung, Cheng-Han Chung, Will Dampier, Will Dampier, Will Dampier, Michael R. Nonnemacher, Michael R. Nonnemacher, Michael R. Nonnemacher, Brian Wigdahl, Brian Wigdahl, Brian Wigdahl, Brian Wigdahl

    Published 2020-08-01
    Get full text
    Article
  5. 5
    Assessment of anti-HIV-1 guide RNA efficacy in cells containing the viral target sequence, corresponding gRNA, and CRISPR/Cas9

    Assessment of anti-HIV-1 guide RNA efficacy in cells containing the viral target sequence, corresponding gRNA, and CRISPR/Cas9 by Alexander G. Allen, Alexander G. Allen, Cheng-Han Chung, Cheng-Han Chung, Stephen D. Worrell, Stephen D. Worrell, Glad Nwaozo, Glad Nwaozo, Rebekah Madrid, Rebekah Madrid, Anthony R. Mele, Anthony R. Mele, Will Dampier, Will Dampier, Michael R. Nonnemacher, Michael R. Nonnemacher, Brian Wigdahl, Brian Wigdahl, Brian Wigdahl

    Published 2023-04-01
    Get full text
    Article
  6. 6
    Safe CRISPR-Cas9 Inhibition of HIV-1 with High Specificity and Broad-Spectrum Activity by Targeting LTR NF-κB Binding Sites

    Safe CRISPR-Cas9 Inhibition of HIV-1 with High Specificity and Broad-Spectrum Activity by Targeting LTR NF-κB Binding Sites by Cheng-Han Chung, Alexander G. Allen, Andrew J. Atkins, Neil T. Sullivan, Greg Homan, Robert Costello, Rebekah Madrid, Michael R. Nonnemacher, Will Dampier, Brian Wigdahl

    Published 2020-09-01
    Get full text
    Article

Search Tools: